Blunt Rochester Legislation Included in Strengthening Health Care and Lowering Prescription Drug Costs Act Passage
The bill included Blunt Rochester’s MORE Health Education Act, reversing ACA marketing and outreach funding cuts
Washington, May 17, 2019 | Kyle Morse (202-695-0494)
WASHINGTON, D.C. — Today, Congresswoman Lisa Blunt Rochester (DE-AL), a member of the House Committee on Energy and Commerce, issued the following statement after voting to pass H.R. 987, the Strengthening Health Care and Lowering Prescription Drug Costs Act. The overall legislation includes Blunt Rochester’s bill, the MORE Health Education Act, which would reverse the 90% funding cut for ACA outreach and marketing. The MORE Health Education Act was also included in the Labor, Health, Human Services, Education, and Related Agencies spending bill, which advanced out of the House Appropriations Committee last week.
The House of Representatives also passed the Blunt Rochester amendment to H.R.987 that will force HHS and CMS to release marketing and outreach data within 30 days of enactment.
“Everywhere I go throughout our state, the concern I hear most is about our health care system. Delawareans feel that their prescription drug costs and premiums are too high. Their budgets are stretched, and they are often forced to choose between paying a medical bill or buying necessities like groceries. Many even choose to skip visits to the doctor because of the costs associated with care. By passing the Strengthening Health Care and Lowering Prescription Drug Costs Act, we are heeding the call for action and taking a step in the right direction,” said Congresswoman Blunt Rochester, a member of the House Committee on Energy and Commerce. “This legislation reverses the Administration’s efforts to sabotage the Affordable Care Act and lowers the cost of prescription drugs for Delaware families, and I was proud to vote for it on the House floor. As we move forward, I will continue to work alongside my colleagues, on both sides of the aisle, to advance bold and innovative solutions that lower the cost of health care, increase access for everyone, and improve the quality of care for all.”
This bipartisan omnibus bill includes three bills to lower prescription drug costs by helping lower-priced generic drugs get to market faster and four measures to reinforce the protections for people with pre-existing conditions and expand enrollment in quality, affordable coverage to more Americans. This bipartisan package invests most of the savings created by the bills promoting generic competition into strengthening our health care system by increasing enrollment in quality coverage and helping interested states set up their own state-based marketplaces, which outperform the Federal marketplace.
The bipartisan legislative package also includes the following four measures to improve our health care system by revoking the Junk Plan rule, thereby reinforcing protections for pre-existing conditions; expanding the number of individuals with quality, affordable coverage; and helping more states create state-based marketplaces: